289 related articles for article (PubMed ID: 15602689)
1. The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine.
Mills EM; Rusyniak DE; Sprague JE
J Mol Med (Berl); 2004 Dec; 82(12):787-99. PubMed ID: 15602689
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology: uncoupling the agony from ecstasy.
Mills EM; Banks ML; Sprague JE; Finkel T
Nature; 2003 Nov; 426(6965):403-4. PubMed ID: 14647371
[TBL] [Abstract][Full Text] [Related]
3. Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy).
Sprague JE; Banks ML; Cook VJ; Mills EM
J Pharmacol Exp Ther; 2003 Apr; 305(1):159-66. PubMed ID: 12649364
[TBL] [Abstract][Full Text] [Related]
4. Roles of norepinephrine, free Fatty acids, thyroid status, and skeletal muscle uncoupling protein 3 expression in sympathomimetic-induced thermogenesis.
Sprague JE; Yang X; Sommers J; Gilman TL; Mills EM
J Pharmacol Exp Ther; 2007 Jan; 320(1):274-80. PubMed ID: 17012607
[TBL] [Abstract][Full Text] [Related]
5. The role of mitochondrial uncoupling in 3,4-methylenedioxymethamphetamine-mediated skeletal muscle hyperthermia and rhabdomyolysis.
Rusyniak DE; Tandy SL; Hekmatyar SK; Mills E; Smith DJ; Bansal N; MacLellan D; Harper ME; Sprague JE
J Pharmacol Exp Ther; 2005 May; 313(2):629-39. PubMed ID: 15644431
[TBL] [Abstract][Full Text] [Related]
6. The preservation of in vivo phosphorylated and activated uncoupling protein 3 (UCP3) in isolated skeletal muscle mitochondria following administration of 3,4-methylenedioxymethamphetamine (MDMA aka ecstasy) to rats/mice.
Kelly OM; McNamara YM; Manzke LH; Meegan MJ; Porter RK
Mitochondrion; 2012 Jan; 12(1):110-9. PubMed ID: 21453795
[TBL] [Abstract][Full Text] [Related]
7. Influence of dietary fats on Ecstasy-induced hyperthermia.
Mills EM; Weaver KL; Abramson E; Pfeiffer M; Sprague JE
Br J Pharmacol; 2007 Aug; 151(7):1103-8. PubMed ID: 17533413
[TBL] [Abstract][Full Text] [Related]
8. MDMA and temperature: a review of the thermal effects of 'Ecstasy' in humans.
Parrott AC
Drug Alcohol Depend; 2012 Feb; 121(1-2):1-9. PubMed ID: 21924843
[TBL] [Abstract][Full Text] [Related]
9. Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasoconstriction induced by 3,4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats.
Blessing WW; Seaman B; Pedersen NP; Ootsuka Y
J Neurosci; 2003 Jul; 23(15):6385-91. PubMed ID: 12867524
[TBL] [Abstract][Full Text] [Related]
10. UCP3 and thyroid hormone involvement in methamphetamine-induced hyperthermia.
Sprague JE; Mallett NM; Rusyniak DE; Mills E
Biochem Pharmacol; 2004 Oct; 68(7):1339-43. PubMed ID: 15345323
[TBL] [Abstract][Full Text] [Related]
11. The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives.
Docherty JR; Green AR
Br J Pharmacol; 2010 Jul; 160(5):1029-44. PubMed ID: 20590597
[TBL] [Abstract][Full Text] [Related]
12. The hyperthermia mediated by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) is sensitive to sex differences.
Wyeth RP; Mills EM; Ullman A; Kenaston MA; Burwell J; Sprague JE
Toxicol Appl Pharmacol; 2009 Feb; 235(1):33-8. PubMed ID: 19121330
[TBL] [Abstract][Full Text] [Related]
13. Distribution of temperature changes and neurovascular coupling in rat brain following 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") exposure.
Coman D; Sanganahalli BG; Jiang L; Hyder F; Behar KL
NMR Biomed; 2015 Oct; 28(10):1257-66. PubMed ID: 26286889
[TBL] [Abstract][Full Text] [Related]
14. Brain hyperthermia induced by MDMA (ecstasy): modulation by environmental conditions.
Brown PL; Kiyatkin EA
Eur J Neurosci; 2004 Jul; 20(1):51-8. PubMed ID: 15245478
[TBL] [Abstract][Full Text] [Related]
15. Acute administration of 3,4-methylenedioxymethamphetamine induces profound hyperthermia, blood-brain barrier disruption, brain edema formation, and cell injury.
Sharma HS; Ali SF
Ann N Y Acad Sci; 2008 Oct; 1139():242-58. PubMed ID: 18991870
[TBL] [Abstract][Full Text] [Related]
16. [Immunomodulator properties of ecstasy (MDMA)].
Pacifici R; Zuccaro P; Farré M; Pichini S; Di Carlo S; Roset PN; Ortuño J; Segura J; Hernández-López C; De La Torre R
Ann Ist Super Sanita; 2000; 36(1):69-75. PubMed ID: 11070610
[TBL] [Abstract][Full Text] [Related]
17. Clinically Relevant Pharmacological Strategies That Reverse MDMA-Induced Brain Hyperthermia Potentiated by Social Interaction.
Kiyatkin EA; Ren S; Wakabayashi KT; Baumann MH; Shaham Y
Neuropsychopharmacology; 2016 Jan; 41(2):549-59. PubMed ID: 26105141
[TBL] [Abstract][Full Text] [Related]
18. 3,4-Methylenedioxymethamphetamine induces a hyperthermic and hypermetabolic crisis in pigs with and without a genetic disposition for malignant hyperthermia.
Schütte JK; Schäfer U; Becker S; Oldewurtel C; Starosse A; Singler P; Richard A; Wappler F; Gerbershagen MU
Eur J Anaesthesiol; 2013 Jan; 30(1):29-37. PubMed ID: 23138574
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits.
Pedersen NP; Blessing WW
J Neurosci; 2001 Nov; 21(21):8648-54. PubMed ID: 11606652
[TBL] [Abstract][Full Text] [Related]
20. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
